解説【LBA4】Phase III study of ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as firstlinetreatment for advanced squamous non-small cell lung cancer (HARMONi-6)【2757O】Tarlatamab with first-line chemoimmunotherapy for extensive stage small cell lung cancer (ESSCLC):DeLLphi-303 study 古屋 直樹 （聖マリアンナ医科大学）
